These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 17032378)

  • 1. A magnetization transfer MRI study of deep gray matter involvement in multiple sclerosis.
    Sharma J; Zivadinov R; Jaisani Z; Fabiano AJ; Singh B; Horsfield MA; Bakshi R
    J Neuroimaging; 2006 Oct; 16(4):302-10. PubMed ID: 17032378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease.
    Vrenken H; Pouwels PJ; Ropele S; Knol DL; Geurts JJ; Polman CH; Barkhof F; Castelijns JA
    Mult Scler; 2007 Jul; 13(6):708-16. PubMed ID: 17613597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of magnetization transfer imaging in judging microchanges lesions in normal-appearing white matter of multiple sclerosis].
    Chu SG; Shen TZ; Chen XR
    Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1181-5. PubMed ID: 15387980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis.
    De Stefano N; Battaglini M; Stromillo ML; Zipoli V; Bartolozzi ML; Guidi L; Siracusa G; Portaccio E; Giorgio A; Sorbi S; Federico A; Amato MP
    Brain; 2006 Aug; 129(Pt 8):2008-16. PubMed ID: 16815879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetization transfer can predict clinical evolution in patients with multiple sclerosis.
    Santos AC; Narayanan S; de Stefano N; Tartaglia MC; Francis SJ; Arnaoutelis R; Caramanos Z; Antel JP; Pike GB; Arnold DL
    J Neurol; 2002 Jun; 249(6):662-8. PubMed ID: 12111296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative diffusion weighted imaging measures in patients with multiple sclerosis.
    Tavazzi E; Dwyer MG; Weinstock-Guttman B; Lema J; Bastianello S; Bergamaschi R; Cosi V; Benedict RH; Munschauer FE; Zivadinov R
    Neuroimage; 2007 Jul; 36(3):746-54. PubMed ID: 17498974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis.
    Parry A; Clare S; Jenkinson M; Smith S; Palace J; Matthews PM
    J Neurol; 2002 Sep; 249(9):1279-86. PubMed ID: 12242554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis.
    Oreja-Guevara C; Charil A; Caputo D; Cavarretta R; Sormani MP; Filippi M
    Arch Neurol; 2006 May; 63(5):736-40. PubMed ID: 16682543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional specificity of magnetization transfer imaging in multiple sclerosis.
    Tjoa CW; Benedict RH; Dwyer MG; Carone DA; Zivadinov R
    J Neuroimaging; 2008 Apr; 18(2):130-6. PubMed ID: 18315593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of focal and diffuse magnetisation transfer abnormalities in multiple sclerosis.
    Laule C; Vavasour IM; Whittall KP; Oger J; Paty DW; Li DK; MacKay AL; Arnold DL
    J Neurol; 2003 Aug; 250(8):924-31. PubMed ID: 12928910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between magnetization transfer metrics and other magnetic resonance abnormalities in multiple sclerosis.
    Rovaris M; Horsfield MA; Filippi M
    Neurology; 1999; 53(5 Suppl 3):S40-5. PubMed ID: 10496210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study.
    Zivadinov R; Heininen-Brown M; Schirda CV; Poloni GU; Bergsland N; Magnano CR; Durfee J; Kennedy C; Carl E; Hagemeier J; Benedict RH; Weinstock-Guttman B; Dwyer MG
    Neuroimage; 2012 Jan; 59(1):331-9. PubMed ID: 21820063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
    Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study.
    Boster A; Hreha S; Berger JR; Bao F; Penmesta R; Tselis A; Endress C; Zak I; Perumal J; Caon C; Vazquez J; Tyler KL; Racke MK; Millis S; Khan O
    Arch Neurol; 2009 May; 66(5):593-9. PubMed ID: 19433659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study.
    Oreja-Guevara C; Rovaris M; Iannucci G; Valsasina P; Caputo D; Cavarretta R; Sormani MP; Ferrante P; Comi G; Filippi M
    Arch Neurol; 2005 Apr; 62(4):578-84. PubMed ID: 15824256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep grey matter "black T2" on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis.
    Zhang Y; Zabad R; Wei X; Metz L; Hill M; Mitchell J
    Mult Scler; 2007 Aug; 13(7):880-3. PubMed ID: 17468444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T2' imaging indicates decreased tissue metabolism in frontal white matter of MS patients.
    Holst B; Siemonsen S; Finsterbusch J; Bester M; Schippling S; Martin R; Fiehler J
    Mult Scler; 2009 Jun; 15(6):701-7. PubMed ID: 19482862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local magnetization transfer ratio signal inhomogeneity is related to subsequent change in MTR in lesions and normal-appearing white-matter of multiple sclerosis patients.
    Chen JT; Collins DL; Freedman MS; Atkins HL; Arnold DL;
    Neuroimage; 2005 May; 25(4):1272-8. PubMed ID: 15850745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI.
    Rovaris M; Gallo A; Valsasina P; Benedetti B; Caputo D; Ghezzi A; Montanari E; Sormani MP; Bertolotto A; Mancardi G; Bergamaschi R; Martinelli V; Comi G; Filippi M
    Neuroimage; 2005 Feb; 24(4):1139-46. PubMed ID: 15670691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetization transfer imaging to monitor clinical trials in multiple sclerosis.
    Richert ND; Frank JA
    Neurology; 1999; 53(5 Suppl 3):S29-32. PubMed ID: 10496208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.